|
2026
|
P/S
|
Pharmaceutical preparations for the treatment of cancer |
|
|
P/S
|
Providing medical information in the field of cancer; Providing a website featuring information i... |
|
|
P/S
|
Pharmaceutical preparations and substances; Medicinal preparations and substances; Vaccines. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous syst... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastroint... |
|
|
P/S
|
Medical information services, namely, providing medical information on the topic of cancer; onlin... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cancer. |
|
|
P/S
|
Antifungal pharmaceutical preparations; Antiviral pharmaceutical preparations; Anti-inflammatory ... |
|
|
P/S
|
Providing medical information in the field of ulcerative colitis, hemophilia, alopecia, and speci... |
|
|
P/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ... |
|
|
P/S
|
Vaccine appointment location, scheduling, and reminder services. Providing wellness services in t... |
|
|
P/S
|
Downloadable software in the nature of a mobile application for providing information and educati... |
|
|
P/S
|
Human vaccine preparations; human vaccines |
|
|
P/S
|
Pharmaceutical research and development; Medical and scientific research in the field of cardiome... |
|
|
P/S
|
Pharmaceutical preparations; vaccines for human use. Providing medical information services relat... |
|
|
Invention
|
Preparation of a pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone derivative and salt thereof.... |
|
|
Invention
|
Compositions and methods for treatment of abnormal cell growth.
This invention relates to oral d... |
|
|
Invention
|
Compounds for the activation of ampk.
Described herein are dosage forms comprising the compound:... |
|
|
Invention
|
Immunogenic compositions for use in pneumococcal vaccines.
An object of the present invention is... |
|
|
Invention
|
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof.
Th... |
|
|
Invention
|
Combinations comprising benzodioxol as glp-1r agonists for use in the treatment of nash/nafld and... |
|
|
Invention
|
Substituted pyridinone compounds and uses thereof. The present disclosure relates to novel pyridi... |
|
|
Invention
|
Proline derivatives and uses thereof. The present disclosure relates to novel proline derivatives... |
|
|
Invention
|
Proline derivatives and uses thereof.
The present disclosure relates to novel proline derivative... |
|
|
Invention
|
Dll3 targeting chimeric antigen receptors and binding agents.
Provided herein are DLL3 binding a... |
|
|
Invention
|
Combination therapy for cancer. A CBP/p300 inhibitor for use in a method of treating or preventin... |
|
|
Invention
|
Combinations of estrogen receptor degraders and kat6 inhibitors. Disclosed herein are methods for... |
|
|
Invention
|
Substituted triazole and imidazole compounds as glucagon-like peptide-1 receptor (glp-1 r) agonis... |
|
|
Invention
|
Dna plasmids. in vitroin vitro transcription (IVT). |
|
|
Invention
|
Methods for treatment of pediatric inflammatory bowel disease with an anti-tl1a antibody. The pre... |
|
|
Invention
|
4-(2-(dimethylamino)-2-oxoethyl)-3-methyl-5-oxo-2,3,4,5-tetrahydrobenzofuro[2,3-f][1,4]oxazepine-... |
|
|
Invention
|
Lipid nanoparticles comprising polymer-conjugated lipids and uses thereof. A lipid nanoparticle f... |
|
|
Invention
|
Fused heterocyclic amide/sulfonamide compounds as agonists of the calcitonin/amylin receptors for... |
|
|
Invention
|
Sulfur-containing heterocycloalkyl substituted bicyclic compounds. The present disclosure relates... |
|
|
Invention
|
Coronavirus and influenza immunogenic combinations. This disclosure relates to the field of RNA t... |
|
2025
|
Invention
|
Combination therapies using cdk4 inhibitors with pd-1 axis binding antagonists. This invention re... |
|
|
Invention
|
Immunogenic compositions and uses thereof. The invention relates to compositions comprising two o... |
|
|
Invention
|
Film coated solid dosage forms for management of dysgeusia. The present invention relates to a fi... |
|
|
Invention
|
Immunogenic compositions and uses thereof.
The invention relates to compositions comprising two ... |
|
|
Invention
|
Immunogenic compositions against influenza. The invention relates to compositions and methods for... |
|
|
Invention
|
Method of cell culture.
A method of cell culture comprising providing cells in a cell culture me... |
|
|
Invention
|
Lipidated tlr7/8 modulators as adjuvants and uses thereof.
The disclosure relates to compounds o... |
|
|
Invention
|
Bckdk inhibitors and/or degraders.
Described herein are compounds of Formula I,
Described here... |
|
|
Invention
|
Human cytomegalovirus gb polypeptide.
The present invention relates to polypeptides and cytomega... |
|
|
Invention
|
Protease-activating cd45-gate car.
A reversibly gated effector polypeptide e.g. a chimeric antig... |
|
|
Invention
|
Tumor necrosis factor-like ligand 1a specific antibodies and compositions and uses thereof.
The ... |
|
2024
|
Invention
|
Kat6a as a predictive biomarker for treatment of breast cancer with a cdk4 inhibitor and an antie... |
|
|
Invention
|
Modulating the innate immunity of rna.
The present disclosure provides methods and compositions ... |
|
|
Invention
|
Systems and methods for annealing frozen bulk in dynamic bulk freeze drying.
The present disclos... |
|
|
Invention
|
Systems and methods for pre-conditioning frozen bulk in dynamic bulk freeze drying.
The present ... |
|
|
Invention
|
Immunogenic compositions and methods of inducing an immune response against varicella zoster viru... |
|
2023
|
Invention
|
Lipid particle compositions and methods of use thereof.
The invention relates to compositions an... |
|
|
Invention
|
Cd47 blocking agent and anti-cd20 / anti-cd3 bispecific antibody combination therapy.
Dosing reg... |
|
|
Invention
|
Method of treating breast cancer.
The invention relates to a method for treating cancer in a sub... |
|
|
Invention
|
Combination of talazoparib and enzalutamide in the treatment of metastatic castration-resistant p... |
|
|
Invention
|
Pneumococcal conjugate vaccine formulations.
The present invention relates to new vaccine formul... |
|
|
Invention
|
Methods for preparing conjugated capsular saccharide antigens and uses thereof.
The present inve... |
|
|
Invention
|
Substituted bicyclic pyridone derivatives.
This disclosure relates to compounds of Formula (I)
... |
|
|
Invention
|
Immunogenic compositions against influenza and rsv.
The present disclosure relates to compositio... |
|
|
Invention
|
Patatin-like phospholipase domain-containing protein 3 (pnpla3) modifiers.
The present invention... |
|
|
Invention
|
2,7-naphthyridine compounds as mastl inhibitors.
The invention relates to compounds of Formula (... |
|
2022
|
Invention
|
Polynucleotide compositions and uses thereof.
The invention relates to RNA molecules encoding an... |
|
|
Invention
|
Methods of treating mitochondrial myopathies using anti-gdf15 antibodies.
The invention provides... |
|
2021
|
Invention
|
Kat6 inhibitor methods and combinations for cancer treatment.
This invention relates to methods ... |
|
2016
|
Invention
|
Anti-il-2 antibodies and compositions and uses thereof. The present invention provides antibodies... |
